Table 1.
Clinical characteristics of ribosomopathies.
DISEASE | GENE DEFECT | CLINICAL FEATURES | TREATMENT | REFERENCES |
---|---|---|---|---|
Diamond-Blackfan anemia (DBA) | 10–15 ribosomal proteins (esp. S19, S26, L5, L11) | Anemia Growth retardation Congenital (esp. craniofacial and thumb) abnormalities |
Corticosteroids Blood transfusions Hematopoietic stem cell transplantation (HSCT) Leucine (?) |
62,100,184 |
5q-syndrome | RPS14 | Anemia | Lenalidomide | 104,115 |
Schwachman-Diamond syndrome (SDS) | SBDS | Exocrine pancreatic insufficiency Hematologic abnormalities (esp. neutropenia) Neurocognitive impairment Gl (esp. liver) abnormalities |
Pancreatic enzyme supplementation HSCT | 121,122 |
X-linked dyskeratosis congenita (DC) | DKC1 | Mucocutaneous abnormalities (e.g. skin pigmentation and nail changes) Pulmonary fibrosis Bone marrow failure |
Oxymetholone HSCT | 135 |
Cartilage-hair hypoplasia (CHH) | RMRP | Short stature Bone deformities Hair growth abnormalities |
Symptomatic | 149 |
Treacher-Collins syndrome (TCS) | TCOF1 | Craniofacial abnormalities | Symptomatic | 156 |
Bowen-Conradi syndrome | EMG1 | Severe growth retardation | None | 162–164 |
North American Indian childhood cirrhosis | hUTP4/Cirhin | Biliary cirrhosis Portal hypertension |
Liver transplantation | 166–168 |